Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2018-03-15 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
106年第4季權益變動表
Interim / Quarterly Report Classification · 85% confidence The document contains detailed financial tables showing changes in equity, including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity. The data is presented for the current period and the previous year, with amounts in thousands of New Taiwan Dollars. The content is a comprehensive financial statement related to equity changes, which is typical of a financial report rather than a brief announcement or certification. The document length is 3564 characters, which is relatively short but contains substantive financial data. Given the nature of the data (equity changes) and the detailed financial figures, this aligns with an Interim / Quarterly Report (IR) rather than a full Annual Report (10-K) or a simple announcement. There is no indication that this is a report publication announcement or a certification. Therefore, the best classification is Interim / Quarterly Report (IR). FY 2017
2018-03-15 Chinese
107年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their family members. It shows changes in shareholdings, types of shares held, and other related insider information. There is no indication of financial statements, earnings data, or meeting materials. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the appropriate classification is DIRS.
2018-03-09 Chinese
107年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and management personnel of the company 科妍生物科技股份有限公司. It lists the number of shares held, pledged shares, and related party holdings. The content focuses on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not a report or announcement of financial results, nor a regulatory filing about changes in board or management. The document is a disclosure of insider shareholdings, which corresponds to the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives.
2018-03-09 Chinese
公告本公司董事會決議庫藏股註銷及訂定減資 基準日
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (806 characters) from a company (1786 科妍) regarding a board resolution about treasury stock cancellation and capital reduction. It includes details such as the date of the board meeting, amount of capital reduction, number of shares cancelled, and related stock information. There is no detailed financial report or analysis, only a regulatory announcement of a corporate action related to capital structure. The document is not a full financial report, audit, or earnings release. It is not a report publication announcement since it contains substantive information about the capital change. The best fitting category is 'Share Issue/Capital Change' (SHA) as it concerns capital reduction and treasury stock cancellation.
2018-03-09 Chinese
公告董事會決議召開107年股東常會相關事宜
AGM Information Classification · 90% confidence The document is a public announcement from a listed company (1786 科妍) regarding the board of directors' resolution to convene the 107th Annual General Meeting (AGM) of shareholders. It includes details such as the date and location of the AGM, agenda items including reports, approvals, discussions, and other procedural matters. The document is short (1086 characters) and primarily serves as a notice about the AGM and its related matters, not the AGM materials or presentations themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or announcements related to it. Given the nature and content, the confidence is high.
2018-03-09 Chinese
董事會決議股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from the company's board chairman regarding the board's resolution on dividend distribution, including details such as cash dividend per share and total dividend amount. It does not contain a full report or detailed financial statements but rather a specific announcement about dividend decisions. The document length is only 679 characters, indicating it is a brief notice rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2018-03-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.